Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
Type:
Grant
Filed:
June 20, 2019
Date of Patent:
April 30, 2024
Assignee:
Ariceum Therapeutics GmbH
Inventors:
Marie Delporte, Sabine Hovest, Jens Kaufmann, Dennis Mewis, Anne Petit, Joel Richard